HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
2.430
-0.060 (-2.41%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.

The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection.

The company was incorporated in 2015 and is based in Santa Clara, California.

HeartBeam, Inc.
HeartBeam logo
Country United States
Founded 2015
IPO Date Nov 11, 2021
Industry Health Information Services
Sector Healthcare
Employees 15
CEO Robert Eno

Contact Details

Address:
2118 Walsh Avenue, Suite 210
Santa Clara, California 95050
United States
Phone 408 899 4443
Website heartbeam.com

Stock Details

Ticker Symbol BEAT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $6.00
CIK Code 0001779372
CUSIP Number 42238H108
ISIN Number US42238H1086
Employer ID 47-4881450
SIC Code 3841

Key Executives

Name Position
Richard M. Ferrari Executive Chairman
Kenneth Persen Chief Technology Officer
Timothy Cruickshank Chief Financial Officer
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. Member of Scientific Advisory Board and Chief Medical Officer
Richa Gujarati Senior Vice President of Product

Latest SEC Filings

Date Type Title
Oct 23, 2024 8-K Current Report
Sep 10, 2024 8-K Current Report
Aug 14, 2024 10-Q Quarterly Report
Jun 18, 2024 8-K Current Report
May 9, 2024 10-Q Quarterly Report
May 3, 2024 424B5 Filing
May 2, 2024 8-K Current Report
Apr 30, 2024 DEF 14A Other definitive proxy statements
Apr 19, 2024 PRE 14A Other preliminary proxy statements
Mar 20, 2024 10-K Annual Report